Clean Yield Group Astrazeneca PLC Transaction History

Clean Yield Group

$311 Million
Q2 2025

A detailed history of Clean Yield Group transactions in Astrazeneca PLC stock. As of the latest transaction made, Clean Yield Group holds 5,900 shares of AZN stock, worth $433,945. This represents 0.13% of its overall portfolio holdings.

Number of Shares

5,900

Previous 5,900 -0.0%

Holding current value

$433,945

Previous $433,000 4.85%

% of portfolio

0.13%

Previous 0.15%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$63.2 - $79.58 $7,204 - $9,072	-114 Reduced 1.9%	5,900 $386,000
Q3 2024 Oct 07, 2024	BUY	$76.67 - $87.62 $8,740 - $9,988	114 Added 1.93%	6,014 $468,000
Q2 2022 Jul 18, 2022	SELL	$59.26 - $71.14 $11,081 - $13,303	-187 Reduced 3.07%	5,900 $390,000
Q1 2022 Apr 25, 2022	BUY	$55.72 - $67.12 $10,419 - $12,551	187 Added 3.17%	6,087 $404,000
Q2 2020 Jul 22, 2020	SELL	$43.1 - $55.31 $34,135 - $43,805	-792 Reduced 11.84%	5,900 $312,000
Q1 2020 Apr 20, 2020	BUY	$37.79 - $51.33 $222,961 - $302,847	5,900 Added 744.95%	6,692 $299,000
Q4 2019 Jan 17, 2020	SELL	$42.46 - $50.46 $250,514 - $297,714	-5,900 Reduced 88.16%	792 $39,000
Q2 2019 Jul 22, 2019	BUY	$37.28 - $41.68 $29,525 - $33,010	792 Added 13.42%	6,692 $276,000
Q1 2019 Apr 24, 2019	BUY	$35.49 - $43.02 $209,391 - $253,818	5,900 New	5,900 $239,000
Q4 2018 Jan 23, 2019	SELL	$36.86 - $41.49 $217,474 - $244,791	-5,900 Closed	0 $0
Q3 2018 Oct 22, 2018	BUY	$34.76 - $39.72 $205,084 - $234,348	5,900 New	5,900 $233,000
Q1 2018 Apr 23, 2018	SELL	$32.97 - $36.63 $194,523 - $216,117	-5,900 Closed	0 $0
Q4 2017 Jan 16, 2018	BUY	$32.09 - $34.78 $189,331 - $205,202	5,900	5,900 $205,000

Others Institutions Holding AZN

# of Institutions

1,421

Shares Held

508M

Call Options Held

9.82M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.

Account

Clean Yield Group Astrazeneca PLC Transaction History